C-Reactive Protein as a Predictor for Airway Hyper-Responsiveness
C-Reactive Protein as a Predictor for Airway Hyper-responsiveness
Sponsor: Rambam Health Care Campus
This observational or N/A phase trial investigates Asthma and is currently completed. Rambam Health Care Campus leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Mar 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rambam Health Care Campus
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.